Japanese AI expert joins Clinical effectiveness

Yuichi Mori, MD, PhD joins the Clinical effectiveness research group as Postdoctoral Fellow. Dr. Mori moves from Showa University Northern Yokohama Hospital in Japan to join the group in Oslo.

Dr. Mori is a gastroenterologist and world expert in Artificial Intelligence (AI) in endoscopy, and will continue to explore and develop this field in cooperation with the group in Oslo.

Yuichi Mori arrived in Oslo in the beginning of April to work as a Postdoctoral Fellow in the Clinical effectiveness research group. He was one of the first scientists in the world to initialize the development of medical and computational equipment to use AI (Artificial Intelligence) in endoscopy practice. He is involved in the research project EndoBRAIN International, and will develop new projects within this field during his stay in Oslo. 

From Japan to corona chaos

Yuichi Mori, MD, PhD from Japan joins Clinical effectiveness research as Postdoctoral Fellow
Yuichi Mori, MD, PhD from Japan joins the Clinical effectiveness research as Postdoctoral Fellow

Mori has relocated to Oslo with his wife Yumi and their 6-year-old daughter Elene. It is easy to imagine that starting a new position in a foreign country during this corona situation is somewhat different and challenging.

– That is true. It is different, but I'm very happy to be here. I wouldn't risk to lose this opportunity, so I decided to start the research visit as planned, in spite of the special circumstances, says Mori.

Award winning researcher

Mori came in contact with Michael Bretthauer in the research group after publishing a paper in Annals of Internal Medicine about AI by Mori in 2018. The Clinical effectiveness research group is internationally renowned for research aiming at developing the endoscopy field, and Mori's experience and competence is a much appreciated addition to these efforts.

Mori was recently awarded the 2020 GIE (Gastrointestinal Endoscopy) and VideoGIE Reviewer Award.

Despite the special circumstances of meeting almost nobody due to home office recommendations, the Clinical effectiveness research group hopes Mori and his family will feel welcome as part of our curious and investigative community.

By Anita Aalby
Published Apr. 28, 2020 3:10 PM - Last modified Apr. 28, 2020 3:21 PM